Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults. Optimization of Clinical Response, Remission, Quality of Life and Analysis of Prognostic Markers

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Population: Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or diffuse systemic sclerosis dSS). Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA. These 5 cohorts will be subject to standardized clinical monitoring.

Who May Be Eligible (Plain English)

Who May Qualify: - Diagnosis of juvenile idiopathic arthritis, rheumatoid arthritis and seronegative / psoriatic / undifferentiated arthritis, systemic lupus erythematosus or diffuse systemic sclerosis (ACR criteria). - Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA. Who Should NOT Join This Trial: - Treated for \> 3 months - \> 50 years old Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Diagnosis of juvenile idiopathic arthritis, rheumatoid arthritis and seronegative / psoriatic / undifferentiated arthritis, systemic lupus erythematosus or diffuse systemic sclerosis (ACR criteria). * Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA. Exclusion Criteria: * Treated for \> 3 months * \> 50 years old

Locations (1)

UCLouvain
Brussels, Belgium